Back to search

Article

LAMAs in Real-Life Asthma Management - The 2023 EU-LAMA Survey Results

2025-06-25

Abstract excerpt

<h4>Background: </h4> Triple therapy (long-acting muscarinic antagonists (LAMAs), long-acting beta agonists (LABAs), inhaled corticosteroids (ICSs) is a recommended treatment for moderate-to-severe asthma at GINA steps 4 and 5. However, little is known about the acceptance and use of triple therapy in everyday practice. The EU-LAMA Survey assessed specialists’ knowledge and views on triple therapy in daily practic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b62e6303-5082-5301-a730-24d74279524c
DOI
10.20944/preprints202506.1958.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
LAMAs in Real-Life Asthma Management - The 2023 EU-LAMA Survey ResultsDOI 10.20944/preprints202506.1958.v1
Select a neighboring publication to make it the new centre.